Alexandria Real Estate Tops Q3 Estimates Despite Occupancy Decline

October 26, 2026 - 22:17

Alexandria Real Estate Equities reported third quarter results that exceeded analyst expectations on both earnings and revenue, even as the company continued to face pressure on occupancy across its life science office portfolio.

The real estate investment trust posted funds from operations that came in above consensus estimates, while revenue for the quarter also topped what Wall Street had forecast. The results suggest the company is managing through a challenging period for the office sector, particularly in markets heavily tied to biotechnology and pharmaceutical tenants.

Occupancy across the portfolio declined during the quarter, reflecting broader softness in demand for laboratory and office space as some life science companies pull back on expansion plans and consolidate their footprints. The drop in occupancy comes as the company works to lease up newer developments and backfill spaces vacated by tenants scaling down operations.

Alongside its quarterly results, the company narrowed its full year guidance range, tightening the outlook it had previously provided to investors. The revised range signals management's confidence in the trajectory of the business while acknowledging ongoing uncertainty in the leasing environment.

Alexandria has been one of the more closely watched REITs given its concentration in the life science niche, which boomed during the pandemic era but has since cooled as funding for biotech startups tightened and larger tenants reassessed their space needs. The company's ability to maintain rental rates and attract quality tenants in this environment remains a key focus for investors.

Shares moved following the release as the market weighed the earnings beat against the occupancy figures and the narrowed forecast.